Medicated Skin Care in Morocco

Medicated Skin Care in Morocco

Euromonitor International's Medicated Skin Care in Morocco report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?
* Get a detailed picture of the medicated skin care industry
* Identify factors driving change
* Understand the competitive environment, the market’s major players and leading brands
* Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning

Medicated Skin Care in Morocco
Euromonitor International
August 2009
List of Contents and Tables
Executive Summary
Health and Wellness Drive Growth of OTC Healthcare in 2008
Cough, Cold and Allergy (hay Fever) Remedies Remains Leading Category
Key Players Remain Active in Their Areas of Operation
Chemists/pharmacies Remains the Leading Channel of Distribution
OTC Healthcare Expected To Benefit From Improvements in Health Education
Key Trends and Developments
Positive Impact of Governmental Health Policies on OTC Healthcare
Improvements in Economy Encourage Growth of OTC Healthcare
Hectic Lifestyles Boost Awareness of Health
Health and Wellness Has Increasing Influence on OTC Healthcare
Chemists/pharmacies, Dominant Distribution Channel in OTC Healthcare
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
Market Data
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
Vitamins & Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Definitions
Summary 1 Research Sources
Afric-phar
Strategic Direction
Key Facts
Summary 2 Afric-Phar: Key Facts
Company Background
Production
Competitive Positioning
Summary 3 Afric-Phar: Competitive Position 2008
Cooper Maroc
Strategic Direction
Key Facts
Summary 4 Cooper Maroc: Key Facts
Summary 5 Cooper Maroc: Operational Indicators
Company Background
Production
Summary 6 Cooper Maroc: Production Statistics 2007
Competitive Positioning
Summary 7 Cooper Maroc: Competitive Position 2008
Laboratoires Laprophan
Strategic Direction
Key Facts
Summary 8 Laboratoires Laprophan: Key Facts
Summary 9 Laboratoires Laprophan: Operational Indicators
Company Background
Production
Summary 10 Laboratoires Laprophan: Production Statistics 2007
Competitive Positioning
Summary 11 Laboratoires Laprophan: Competitive Position 2008
Laboratoires Pharma 5
Strategic Direction
Key Facts
Summary 12 Laboratoires Pharma 5: Key Facts
Summary 13 Laboratoires Pharma 5: Operational Indicators
Company Background
Competitive Positioning
Summary 14 Laboratoires Pharma 5: Competitive Position 2008
Laboratoires Sothema
Strategic Direction
Key Facts
Summary 15 Laboratoires Sothema: Key Facts
Summary 16 Laboratoires Sothema: Operational Indicators
Company Background
Production
Summary 17 Laboratoires Sothema: Production Statistics 2007
Competitive Positioning
Summary 18 Laboratoires Sothema: Competitive Position 2008
Maphar, Laboratoires
Strategic Direction
Key Facts
Summary 19 Maphar, Laboratoires: Key Facts
Summary 20 Maphar, Laboratoires: Operational Indicators
Company Background
Competitive Positioning
Summary 21 Maphar, Laboratoires: Competitive Position 2008
Promopharm
Strategic Direction
Key Facts
Summary 22 Promopharm: Key Facts
Summary 23 Promopharm: Operational Indicators
Company Background
Competitive Positioning
Summary 24 Promopharm: Competitive Position 2008
Smp Bottu
Strategic Direction
Key Facts
Summary 25 SMP Bottu: Key Facts
Summary 26 SMP Bottu: Operational Indicators
Company Background
Competitive Positioning
Summary 27 SMP Bottu: Competitive Position 2008
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 11 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 12 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 13 Herbal vs Standard Medicated Skin Care 2003-2008
Table 14 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 15 Medicated Skin Care Company Shares by Value 2004-2008
Table 16 Medicated Skin Care Brand Shares by Value 2005-2008
Table 17 Acne Treatments Brand Shares by Value 2005-2008
Table 18 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 19 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 20 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013